Oramed Pharmaceuticals Free Cash Flow 2011-2024 | ORMP
Oramed Pharmaceuticals Annual Free Cash Flow | |
---|---|
2023 | -10.55 |
2022 | -28.39 |
2021 | -11.13 |
2021 | -21.56 |
2020 | -12.52 |
2019 | -12.96 |
2018 | -14.66 |
2017 | -5.84 |
2016 | 4.65 |
2015 | -4.95 |
2014 | -4.08 |
2013 | -3.40 |
2012 | |
2012 | -2.30 |
2011 | 0.02 |
2011 | -1.71 |
2010 | -0.49 |
Oramed Pharmaceuticals Quarterly Free Cash Flow | |
---|---|
2024-06-30 | 0.60 |
2024-03-31 | -1.48 |
2023-12-31 | -10.55 |
2023-09-30 | -9.13 |
2023-06-30 | -8.40 |
2023-03-31 | -5.75 |
2022-12-31 | -28.39 |
2022-09-30 | -20.04 |
2022-06-30 | -17.68 |
2022-03-31 | -9.17 |
2021-12-31 | -11.13 |
2021-11-30 | -6.90 |
2021-09-30 | -13.95 |
2021-08-31 | |
2021-06-30 | -8.39 |
2021-05-31 | -15.39 |
2021-03-31 | -3.71 |
2021-02-28 | -9.75 |
2020-11-30 | -6.47 |
2020-08-31 | |
2020-05-31 | -9.99 |
2020-02-29 | -6.63 |
2019-11-30 | -3.00 |
2019-08-31 | |
2019-05-31 | -9.69 |
2019-02-28 | -6.02 |
2018-11-30 | -4.14 |
2018-08-31 | |
2018-05-31 | -10.01 |
2018-02-28 | -6.21 |
2017-11-30 | -2.73 |
2017-08-31 | |
2017-05-31 | -3.79 |
2017-02-28 | -1.43 |
2016-11-30 | 1.50 |
2016-08-31 | |
2016-05-31 | -2.16 |
2016-02-29 | 0.08 |
2015-11-30 | -2.25 |
2015-08-31 | |
2015-05-31 | -3.92 |
2015-02-28 | -3.01 |
2014-11-30 | -1.40 |
2014-08-31 | |
2014-05-31 | -3.28 |
2014-02-28 | -2.24 |
2013-11-30 | -0.75 |
2013-08-31 | |
2013-05-31 | -3.12 |
2013-02-28 | -2.07 |
2012-12-31 | |
2012-11-30 | -0.79 |
2012-08-31 | |
2012-05-31 | -1.96 |
2012-02-29 | -1.08 |
2011-11-30 | -0.48 |
2011-09-30 | |
2011-08-31 | |
2011-06-30 | -0.49 |
2011-05-31 | -1.29 |
2011-03-31 | 0.53 |
2011-02-28 | -0.70 |
2010-12-31 | -0.49 |
2010-11-30 | -0.50 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.096B | $0.001B |
Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $203.272B | 26.25 |
Stryker (SYK) | United States | $140.156B | 32.75 |
Boston Scientific (BSX) | United States | $123.450B | 37.59 |
Medtronic (MDT) | Ireland | $115.424B | 17.18 |
EssilorLuxottica (ESLOY) | France | $105.988B | 0.00 |
Haleon (HLN) | United Kingdom | $47.352B | 34.60 |
Lonza Group Ag (LZAGY) | Switzerland | $46.218B | 0.00 |
ResMed (RMD) | United States | $36.837B | 32.43 |
Koninklijke Philips (PHG) | Netherlands | $28.913B | 21.97 |
Terumo (TRUMY) | Japan | $27.831B | 39.31 |
Zimmer Biomet Holdings (ZBH) | United States | $21.412B | 13.48 |
Baxter (BAX) | United States | $20.091B | 13.63 |
Insulet (PODD) | United States | $16.158B | 67.98 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.705B | 0.00 |
Demant (WILYY) | Denmark | $9.197B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.972B | 29.73 |
BellRing Brands (BRBR) | United States | $7.584B | 32.07 |
Lantheus Holdings (LNTH) | United States | $7.223B | 17.34 |
ICU Medical (ICUI) | United States | $4.254B | 40.60 |
Haemonetics (HAE) | United States | $3.749B | 18.55 |
Perrigo (PRGO) | Ireland | $3.702B | 11.70 |
Prestige Consumer Healthcare (PBH) | United States | $3.613B | 18.00 |
TG Therapeutics (TGTX) | United States | $3.590B | 38.02 |
GN Store Nord (GNNDY) | Denmark | $3.560B | 21.44 |
Neogen (NEOG) | United States | $3.357B | 35.23 |
Envista Holdings (NVST) | United States | $3.210B | 17.13 |
QuidelOrtho (QDEL) | United States | $3.012B | 18.98 |
Agios Pharmaceuticals (AGIO) | United States | $2.556B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.190B | 36.75 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.172B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.981B | 52.80 |
AdaptHealth (AHCO) | United States | $1.451B | 10.48 |
Warby Parker (WRBY) | United States | $1.445B | 0.00 |
InMode (INMD) | Israel | $1.407B | 8.96 |
AtriCure (ATRC) | United States | $1.349B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.124B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.120B | 0.00 |
Owens & Minor (OMI) | United States | $1.109B | 8.57 |
Evolus (EOLS) | United States | $1.039B | 0.00 |
PetIQ (PETQ) | United States | $0.916B | 23.23 |
Phibro Animal Health (PAHC) | United States | $0.859B | 17.82 |
National Vision Holdings (EYE) | United States | $0.816B | 25.95 |
Cresco Labs (CRLBF) | United States | $0.810B | 0.00 |
Surmodics (SRDX) | United States | $0.557B | 118.21 |
Valneva SE (VALN) | France | $0.486B | 0.00 |
Quanterix (QTRX) | United States | $0.479B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.470B | 14.17 |
ZimVie (ZIMV) | United States | $0.448B | 41.64 |
Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
Jin Medical (ZJYL) | China | $0.394B | 0.00 |
Cerus (CERS) | United States | $0.378B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.341B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.318B | 8.19 |
Biote (BTMD) | United States | $0.311B | 14.32 |
Aurora Cannabis (ACB) | Canada | $0.309B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.303B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.290B | 31.12 |
Zynex (ZYXI) | United States | $0.250B | 43.83 |
Ayr Wellness (AYRWF) | United States | $0.233B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.229B | 15.22 |
MacroGenics (MGNX) | United States | $0.226B | 0.00 |
Omeros (OMER) | United States | $0.217B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
High Tide (HITI) | Canada | $0.177B | 0.00 |
FitLife Brands (FTLF) | United States | $0.155B | 20.87 |
TriSalus Life Sciences (TLSI) | United States | $0.151B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.136B | 0.00 |
Brainsway (BWAY) | Israel | $0.134B | 161.00 |
Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
Veru (VERU) | United States | $0.122B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.120B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
Fonar (FONR) | United States | $0.105B | 10.61 |
InterCure (INCR) | Israel | $0.090B | 15.15 |
Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.073B | 0.00 |
Safety Shot (SHOT) | United States | $0.072B | 0.00 |
Modular Medical (MODD) | United States | $0.071B | 0.00 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
Exagen (XGN) | United States | $0.052B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.050B | 3.25 |
Apyx Medical (APYX) | United States | $0.043B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
Bright Green (BGXX) | United States | $0.039B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
Nephros (NEPH) | United States | $0.020B | 0.00 |
GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
Flora Growth (FLGC) | United States | $0.012B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
Sharps Technology (STSS) | United States | $0.007B | 0.00 |
Agape ATP (ATPC) | $0.006B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 20.07 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |